Garwood Medical Devices
Garwood Medical Devices focuses on advancing implant infection control through innovative technologies, including the BioPrax™ device, which is under investigation for FDA marketing authorization and has shown significant effectiveness in eliminating biofilm infections on prosthetic knee implants.
Company Overview
Garwood Medical Devices is dedicated to advancing the field of implant infection control through innovative technologies. The company's primary focus is on developing early intervention treatments to enhance implant retention and potentially improve outcomes for patients. They aim to revolutionize implant infection management, particularly with their BioPrax™ device, which has shown promise in initial studies.
Flagship Product: BioPrax™
BioPrax™ is Garwood Medical Devices' leading technology, currently under investigation for FDA marketing authorization. It targets biofilm infections on prosthetic knee implants, which are a significant cause of implant failure. BioPrax™ has been granted FDA Breakthrough Device Designation and has demonstrated up to 99.6% effectiveness in eliminating biofilms, including those caused by drug-resistant bacteria like MRSA and E. Coli. The device involves a minimally invasive procedure and requires minimal training for healthcare professionals.
FDA Breakthrough Device Designation
In October 2019, Garwood Medical Devices received FDA Breakthrough Device designation for BioPrax™, recognizing its potential to effectively address a critical, unmet medical need. This designation accelerates the review process, potentially bringing BioPrax™ to market more quickly, and underscores the promise the device holds in improving outcomes for patients with infected implants.
Innovations in Implant Infection Control
Garwood Medical Devices is pioneering technologies and treatments that use low voltage electrochemical disruption to target and eliminate biofilm infections. These innovations aim to retain the original implant, reduce infection rates, and improve patient outcomes. Their approach is a significant step forward in managing and preventing implant-related infections.
Partnerships and Recognitions
Garwood Medical Devices collaborates with the University at Buffalo and numerous private and public organizations. The company was named an awardee in the Innovations for Vets QuickFire Challenge by Johnson & Johnson Innovation, granting them access to funding, the Johnson & Johnson Innovation-JLABS ecosystem, and mentorship. Their presence at key industry events, such as the American Academy of Orthopaedic Surgeons Annual Meeting and the Orthopaedic Research Society Annual Meeting, highlights their active role in the medical device community.